Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)

被引：1
|
作者：
Furqan, M. [1 ]
Zhang, J. [1 ]
Clamon, G. [1 ]
Abu-Hejleh, T. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Med, Iowa City, IA 52242 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Gemcitabine; nab-paclitaxel; small cell lung cancer;
D O I：
10.1016/j.jtho.2018.08.1378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.12-02
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [41] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024, 29 (10): : e1406 - e1418
  • [42] Phase II study of irinotecan and paclitaxel for patients with recurrent small cell lung cancer (SCLC)
    Owonikoko, T. K.
    Ramalingam, S.
    Forster, J.
    Shuai, Y.
    Evans, T.
    Gooding, W. E.
    Sulecki, M.
    Belani, C. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer (SCLC)
    Pietanza, M. C.
    Sima, C. S.
    Polley, M. R.
    Sumner, D. K.
    Travis, V.
    Heguy, A.
    Ginsberg, M. S.
    Holodny, A.
    Kris, M. G.
    Krug, L. M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S507 - S507
  • [44] GEMCITABINE AND NAB-PACLITAXEL FOR PEDIATRIC RELAPSED AND REFRACTORY SOLID TUMORS
    Metts, Jonathan
    Clark, Dana
    Alazraki, Adina
    Wasilewski-Masker, Karen
    George, Bradley
    Olson, Thomas
    Cash, Thomas
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S8 - S8
  • [45] Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study
    Rivera, Fernando
    Benavides, Manuel
    Gallego, Javier
    Guillen-Ponce, Carmen
    Lopez-Martin, Jose
    Kung, Marc
    PANCREATOLOGY, 2019, 19 (01) : 64 - 72
  • [46] Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer
    Yamamoto, N
    Tsurutani, J
    Yoshimura, N
    Asai, G
    Moriyama, A
    Nakagawa, K
    Kudoh, S
    Takada, M
    Minato, Y
    Fukuoka, M
    ANTICANCER RESEARCH, 2006, 26 (1B) : 777 - 781
  • [47] Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Blaydorn, Lisa
    Beck, Julia
    Bornemann-Kolatzki, Kirsten
    Urnovitz, Howard
    Schutz, Ekkhard
    Khemka, Vivek
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 96 - 102
  • [48] Gemcitabine nab-paclitaxel combination with DMAPT in PDAC cachexia
    Counts, Brittany
    Jean, Sephora
    Wang, Reggie
    Zimmers, Teresa
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel in the management of advanced pancreatic cancer
    Kommalapati, A.
    Kim, R.
    Harsha, T. Sri
    Bertels, B.
    Wapinsky, G.
    Burke, N.
    Neuger, A.
    Springett, G.
    Almhanna, K.
    Mahipal, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E135 - E135
  • [50] Phase 1 trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer
    Mahipal, Amit
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Goyal, Gaurav
    Soares, Heloisa
    Neuger, Anthony
    Copolla, Domenico
    Kim, Jongphil
    Kim, Richard
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 473 - 481
12345